تحميل...

The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

BACKGROUND: The promotility agents currently available to treat gastroparesis and feed intolerance in the critically ill are limited by adverse effects. The aim of this study was to assess the pharmacodynamic effects and pharmacokinetics of single doses of the novel gastric promotility agent motilin...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Crit Care
المؤلفون الرئيسيون:	Chapman, Marianne J., Deane, Adam M., O’Connor, Stephanie L., Nguyen, Nam Q., Fraser, Robert J. L., Richards, Duncan B., Hacquoil, Kimberley E., Vasist Johnson, Lakshmi S., Barton, Matthew E., Dukes, George E.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BioMed Central 2016
الموضوعات:	Research
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4967996/ https://ncbi.nlm.nih.gov/pubmed/27476581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1420-4
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

مواد مشابهة